Mabanta, Jimmy C.

HRN: 20-80-81  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2025
CEFTAZIDIME 1GM (VIAL)
07/30/2025
08/05/2025
IV
1g
Q8h
CAPMR
Checking Initial Appropriateness 
07/30/2025
AZITHROMYCIN 500MG TABLET (TAB)
07/30/2025
08/03/2025
PO
500mg
OD
CAPMR
Checking Initial Appropriateness 
08/08/2025
CEFIXIME 200MG (CAP)
08/08/2025
08/15/2025
PO
200 Mg
Q12 Hrs
TB Bronchiectasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: